Literature DB >> 19470785

Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E).

Huijing Fu1, Jun He, Fan Mei, Qi Zhang, Yukihiko Hara, Seto Ryota, Ronald A Lubet, Ruth Chen, Da-Ren Chen, Ming You.   

Abstract

Green tea has been shown to exhibit cancer-preventive activities in preclinical studies. However, (-)-epigallocatechin-3-gallate (EGCG) alone was shown to be ineffective in preventing lung tumorigenesis in mice by aerosol administration. In this study, Polyphenon E and Polyphenon E without EGCG were administered by aerosol delivery to A/J mice 2 weeks after carcinogen treatment and continuing daily throughout the remainder of the study (20 weeks). An improved aerosol delivery system with a custom-built atomizer, an efficient solvent remove system, and a nose-only exposure chamber was used to provide aerosols with stable size distribution. There were no significant differences in the size distributions of Polyphenon E and Polyphenon E without EGCG. With a relatively low dose level (4.19 mg/kg), Polyphenon E decreased tumor multiplicity by 53%, whereas Polyphenon E without EGCG at the same dose failed to inhibit lung carcinogenesis. These results indicate that aerosol administration can be an effective approach in chemoprevention study, and aerosolized Polyphenon E can significantly inhibit pulmonary adenoma formation and growth in A/J mice. Furthermore, in aerosolized form, EGCG, which is thought to be the most active component of Polyphenon E, has to be present with other tea catechins to show chemopreventive activity on lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470785     DOI: 10.1158/1940-6207.CAPR-08-0185

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  15 in total

1.  Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors.

Authors:  Mark E Stearns; Min Wang
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.

Authors:  Qi Zhang; Jing Pan; Ronald A Lubet; Steven M Komas; Balaraman Kalyanaraman; Yian Wang; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-02

3.  Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Authors:  Katherine D Crew; Powel Brown; Heather Greenlee; Therese B Bevers; Banu Arun; Clifford Hudis; Heather L McArthur; Jenny Chang; Mothaffar Rimawi; Lana Vornik; Terri L Cornelison; Antai Wang; Hanina Hibshoosh; Aqeel Ahmed; Mary Beth Terry; Regina M Santella; Scott M Lippman; Dawn L Hershman
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-24

4.  Chemoprevention of lung tumorigenesis by intranasally administered diindolylmethane in A/J mice.

Authors:  Xuemin Qian; Jung Min Song; Tamene Melkamu; Pramod Upadhyaya; Fekadu Kassie
Journal:  Carcinogenesis       Date:  2012-12-13       Impact factor: 4.944

5.  Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice.

Authors:  Qi Zhang; Huijing Fu; Jing Pan; Jun He; Seto Ryota; Yukihiko Hara; Yian Wang; Ronald A Lubet; Ming You
Journal:  Pharm Res       Date:  2010-01-29       Impact factor: 4.200

6.  Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.

Authors:  Huijing Fu; Jingjie Zhang; Jing Pan; Qi Zhang; Yan Lu; Weidong Wen; Ronald A Lubet; Eva Szabo; Ruth Chen; Yian Wang; Da-Ren Chen; Ming You
Journal:  Mol Carcinog       Date:  2011-03-03       Impact factor: 4.784

Review 7.  Green tea and prevention of esophageal and lung cancers.

Authors:  Jian-Min Yuan
Journal:  Mol Nutr Food Res       Date:  2011-04-29       Impact factor: 5.914

Review 8.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

9.  Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Authors:  Anne S Tsao; Diane Liu; Jack Martin; Xi-ming Tang; J Jack Lee; Adel K El-Naggar; Ignacio Wistuba; Kirk S Culotta; Li Mao; Ann Gillenwater; Yuko M Sagesaka; Waun K Hong; Vassiliki Papadimitrakopoulou
Journal:  Cancer Prev Res (Phila)       Date:  2009-11

Review 10.  Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.

Authors:  Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.